RHY rhythm biosciences limited

In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034

  1. 377 Posts.
    lightbulb Created with Sketch. 116
    An interesting 'big picture' news article from Biopharma...

    In Vitro Diagnostics (IVD) Market Size to Surpass USD 157.56 Billion by 2034 - BioSpace.pdf

    Lab Developed Tests, otherwise known as In-House Tests, are IVD tests endorsed by a particular lab without the need for costly and lengthy FDA or TGA, or equivalent approval. This type of commercial pathway specifically exists so innovative tests, such as Colostat, can be utilised sooner to benefit patients without heavy approval cost burdens. The pathway also allows for data collection along the way to be used for potential future FDA/TGA approval.

    Not surprisingly, there is continuing massive growth in Contract Manufacturing Labs because their inclusion in the process facilitates the increasing demand for rapid scientific developments in healthcare, such as Colostat!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
11.0¢
Change
-0.025(18.5%)
Mkt cap ! $31.24M
Open High Low Value Volume
13.5¢ 15.0¢ 11.0¢ $505.6K 3.933M

Buyers (Bids)

No. Vol. Price($)
4 335088 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 5000 1
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.